Latest Biomarker Stories
LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012.
-New Preclinical Results Increase Mechanistic Understanding of Targeting miR-103/107 for Metabolic Disorders and miR-21 for Renal Dysfunction in Alport Syndrome Patients- LA JOLLA, Calif.,
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S.
According to new report from BCC Research, the global market for next generation (next gen) cancer diagnostics is expected to grow to $10.6 billion by 2019, with a five-year compound annual growth
GHENT, Belgium and MADRID, October 7, 2014 /PRNewswire/ -- MyCartis today announced the launch of Evalution(TM), a multiplex biomarker analysis platform for the life sciences
Circulating metabolite could predict abnormalities in body's response to a 'glucose challenge' as substitute for oral glucose tolerance test (OGTT) RICHMOND, Va., Oct.
MENLO PARK, Calif., Oct.
Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct.
Life Length, the world leader in telomere analysis, is pleased to add Cleveland HeartLab to their current list of partner labs from across the globe. Madrid,
NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.
More Images (2 images) »